Heart Failure Drugs: Diuretics
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Principles of Drug Action
Heart Failure Drugs: Inotropic Agents
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 26, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
No abstract available in PubMed .